Glow Holdings, Inc. (GLOH: OTC Pink Current) | Glow

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Glow Holdings, Inc. (GLOH: OTC Pink Current) | Glow Holdings Inc. Announces Binding Letter of Intent to Acquire Cedar River Foods LLC and Announces New Chief Executive Officer Glow Holdings Inc. Announces Binding Letter of Intent to Acquire Cedar River Foods LLC and Announces New Chief Executive Officer

Glow Holdings Inc. Announces Binding Letter of Intent to Acquire Cedar River Foods LLC and Announces New Chief Executive Officer

IRVINE, CA--(Marketwired - Apr 23, 2014) - Glow Holdings Inc. ( PINKSHEETS : GLOH ) announced today that it signed a binding Letter of Intent ("LOI") with Cedar River Foods LLC calling for a newly-formed subsidiary of Glow to merge with Cedar River Foods' operations. According to Robert Pang, Chairman and Chief Visionary of Glow's Visionary Board, "This is a major milestone for Glow that is taking its first step in executing its strategic plan, using mergers and acquisitions to acquire strategic operations."

Cedar River Foods LLC is a food manufacturer based in Seattle, Washington. Cedar River Foods uses innovative, proprietary technology and expertise to make unique, delicious food products. The Ultimate Pancake Sandwich is the first product launched by Cedar River Foods, and can be found in grocery stores such as Kroger, Thriftway, as well as other specialty retailers.

Cedar River Foods is committed to using only the highest quality ingredients. The company selects 100% natural sausages, real cheddar cheese, and no artificial colors or additives. The products are low in calories and fat, with no trans fats or GMO (genetically-modified organisms) ingredients.

Under the LOI, the plan is for Cedar River Foods to merge with and into a 55%-owned subsidiary of Glow to be called Cedar Foods Corporation (CFC) and the other 45% to be owned by Ambezz Inc., with Cedar Foods Corporation being the surviving entity after the merger. According to the LOI, in the event the merger closes, the membership unit holders of Cedar River Foods LLC and the shareholders of Ambezz Inc., as of immediately prior to the closing of the merger, will receive twenty-five million (25,000,000) newly-issued shares of Glow Common Stock, restricted in accordance with Rule 144, and Glow agrees to invest a minimum of $125,000, between the closing and August 15, 2014, in the new Cedar Foods Corporation for the development of its business.

Additionally, Glow announced the appointment of Robert J. Selfridge as its new Chief Executive Officer as well as Cedar Foods Corporation. Mr. Selfridge is co-founder and Managing Partner of Cedar River Foods LLC. Prior to Cedar River Foods LLC, Selfridge was Senior Adviser to the Chairman of Foodx Globe Co. Ltd., a Japanese Holdings Company operating food services and other retail concepts around the world. Before joining Foodx, Selfridge was Executive Vice President of Tully's Coffee Corp., managing domestic USA operations and international expansion of the specialty coffee retailer into Europe and Asia.

About Glow Holdings Inc.
Glow Holdings Inc. ( PINKSHEETS : GLOH ) is a diversified holdings company with headquarters to be based in Seattle, Washington. The company is embarking on an accelerated business growth and diversification program, "Grow with GLOW," to increase the valuation of the company's assets with the implementation of the development program. The company's management believes that the fastest way for Glow to grow is through mergers and acquisitions in companies that are strategically placed in industries which have the highest potential. Glow's management team has the right experience, tools, and skills to provide business models and services like marketing, product and brand development, revenue streams strategies, corporate governance, sales strategies, and raising capital funds to provide the means for Glow to generate multiple streams of income, while helping its acquisitions and new start-up companies become successful and profitable. In addition to providing a capital base and know-how, the company plans to invigorate the sales and marketing of each entity through an innovative marketing program, including integrated online sales (e-commerce) channels, platforms, programs and strategies.

"Grow with GLOW"

Forward Looking Statements
This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the company's control. The forward-looking statements are also identified through the use of words such as "believe", "enable", "may", "will", "could", "intends", "estimates", "anticipates", "plans", "predicts", "probable", "potential", "possible", "should", "continue", and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of factors. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved.

For more information, contact:
Robert Pang
bobby.pang@atglow.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 135

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 35

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 20

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 78

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 70

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 29

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 194

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 119

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 117

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 59

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading

Top 5 Most Recently Viewed Articles

Ocuphire Pharma Faces Scrutiny Over Shareholder Obligations

Updated Category News Views 81

Ocuphire Pharma Under Investigation by Ademi LLP Recently, there have been growing concerns regarding the fiduciary responsibilities of Ocuphire Pharma, Inc. (NASDAQ: OCUP) to its public shareholders. Ademi LLP has initiated an investigation focused on whether the company is adequately protecting the interests of its shareholders amidst its dealings with Opus Genetics....

Continue Reading
Investigation Into Shareholder Claims Against AMLX, FIVE, HUM, and VSTS

Updated Category News Views 190

Grabar Law Office Investigates Shareholders' Rights Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Five Below, Inc. (NASDAQ: FIVE), Humana Inc. (NYSE: HUM), and Vestis Corp. (NYSE: VSTS) shareholders may have claims worth exploring. Grabar Law Office wants to inform these shareholders about the ongoing investigations into potential securities fraud that could have affected...

Continue Reading
Investors Seek Recovery in Class Action Against Paragon 28, Inc.

Updated Category News Views 109

Class Action Lawsuit Filed for Paragon 28, Inc. Investors We are reaching out to inform investors about an important class action securities lawsuit involving Paragon 28, Inc. This initiative aims to recover losses for investors who may have been adversely affected by purported securities fraud associated with the company. Details of the Class Action The class action...

Continue Reading
Alto Ingredients, Inc. Announcement for Q2 2025 Results

Updated Category News Views 165

Alto Ingredients, Inc. to Announce Second Quarter Financial Results Alto Ingredients, Inc. (NASDAQ: ALTO), a prominent producer and distributor of specialty alcohols and renewable fuels, is set to release its financial results for the second quarter of 2025. This announcement will take place after the market closes on Wednesday, August 6, 2025. Conference Call Details...

Continue Reading
Phare Bio Secures $27 Million to Revolutionize Antibiotic Discovery

Updated Category News Views 226

Phare Bio scored big back in 2024 with up to $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). This isn’t just pocket change; it’s a lifeline aimed at supercharging their generative artificial intelligence (AI) platform. Teaming up with MIT's Collins Lab and Harvard's Wyss Institute, they set their sights on developing new classes...

Continue Reading